Works in Cancer Chemotherapy & Pharmacology, 2013, Vol 71, Issue 1

Results: 31

Phase I study of 5-aza-2'-deoxycytidine in combination with valproic acid in non-small-cell lung cancer.
Published in:
2013
By:
- Chu BF;
- Karpenko MJ;
- Liu Z;
- Aimiuwu J;
- Villalona-Calero MA;
- Chan KK;
- Grever MR;
- Otterson GA;
- Chu, B F;
- Karpenko, M J;
- Liu, Z;
- Aimiuwu, J;
- Villalona-Calero, M A;
- Chan, K K;
- Grever, M R;
- Otterson, G A
Publication type:
journal article
Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 245, doi. 10.1007/s00280-012-2002-z
By:
- Pliarchopoulou, K.;
- Kalogeras, K.;
- Kronenwett, R.;
- Wirtz, R.;
- Eleftheraki, A.;
- Batistatou, A.;
- Bobos, M.;
- Soupos, N.;
- Polychronidou, G.;
- Gogas, H.;
- Samantas, E.;
- Christodoulou, C.;
- Makatsoris, T.;
- Pavlidis, N.;
- Pectasides, D.;
- Fountzilas, G.
Publication type:
Article
PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 133, doi. 10.1007/s00280-012-1988-6
By:
- Choo, Edna;
- Ng, Chee;
- Berry, Leanne;
- Belvin, Marcia;
- Lewin-Koh, Nicholas;
- Merchant, Mark;
- Salphati, Laurent
Publication type:
Article
Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 153, doi. 10.1007/s00280-012-1992-x
By:
- Litviakov, Nicolay;
- Cherdyntseva, Nadezhda;
- Tsyganov, Matvey;
- Denisov, Evgeny;
- Garbukov, Evgeny;
- Merzliakova, Marina;
- Volkomorov, Victor;
- Vtorushin, Sergey;
- Zavyalova, Marina;
- Slonimskaya, Elena;
- Perelmuter, Vladimir
Publication type:
Article
Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 53, doi. 10.1007/s00280-012-1972-1
By:
- Kerklaan, Bojana;
- Diéras, Veronique;
- Tourneau, Christophe;
- Mergui-Roelvink, Marja;
- Huitema, Alwin;
- Rosing, Hilde;
- Beijnen, Jos;
- Marreaud, Sandrine;
- Govaerts, Anne-Sophie;
- Piccart-Gebhart, Martine;
- Schellens, Jan;
- Awada, Ahmad
Publication type:
Article
Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 103, doi. 10.1007/s00280-012-1983-y
By:
- Zhang, Jian;
- Gu, Shi-Yang;
- Gan, Yu;
- Wang, Zhong-Hua;
- Wang, Bi-Yun;
- Guo, Hai-Yi;
- Wang, Jia-Lei;
- Wang, Lei-Ping;
- Zhao, Xin-Min;
- Hu, Xi-Chun
Publication type:
Article
Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 85, doi. 10.1007/s00280-012-1981-0
By:
- Takahara, Naminatsu;
- Nakai, Yousuke;
- Isayama, Hiroyuki;
- Sasaki, Takashi;
- Satoh, Yumiko;
- Takai, Daiya;
- Hamada, Tsuyoshi;
- Uchino, Rie;
- Mizuno, Suguru;
- Miyabayashi, Koji;
- Mohri, Dai;
- Kawakubo, Kazumichi;
- Kogure, Hirofumi;
- Yamamoto, Natsuyo;
- Sasahira, Naoki;
- Hirano, Kenji;
- Ijichi, Hideaki;
- Tada, Minoru;
- Yatomi, Yutaka;
- Koike, Kazuhiko
Publication type:
Article
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 63, doi. 10.1007/s00280-012-1977-9
By:
- Esteva, Francisco;
- Moulder, Stacy;
- Gonzalez-Angulo, Ana;
- Ensor, Joe;
- Murray, James;
- Green, Marjorie;
- Koenig, Kimberly;
- Lee, Mong-Hong;
- Hortobagyi, Gabriel;
- Yeung, Sai-Ching
Publication type:
Article
Pharmacokinetic-pharmacodynamic relationship of bosutinib in patients with chronic phase chronic myeloid leukemia.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 209, doi. 10.1007/s00280-012-1998-4
By:
- Hsyu, Poe-Hirr;
- Mould, Diane;
- Upton, Richard;
- Amantea, Michael
Publication type:
Article
Association between KRAS codon 13 mutations and clinical response to anti-EGFR treatment in patients with metastatic colorectal cancer: results from a meta-analysis.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 265, doi. 10.1007/s00280-012-2005-9
By:
- Chen, Jian;
- Ye, Yun;
- Sun, Haozhen;
- Shi, Genming
Publication type:
Article
Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 29, doi. 10.1007/s00280-012-2023-7
By:
- Kusaba, Hitoshi;
- Esaki, Taito;
- Kishimoto, Junji;
- Uchino, Keita;
- Arita, Shuji;
- Kumagai, Hozumi;
- Mitsugi, Kenji;
- Akashi, Koichi;
- Baba, Eishi
Publication type:
Article
Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 183, doi. 10.1007/s00280-012-1995-7
By:
- Ott, Patrick;
- Chang, Jason;
- Madden, Kathleen;
- Kannan, Rajni;
- Muren, Caroline;
- Escano, Crystal;
- Cheng, Xin;
- Shao, Yongzhao;
- Mendoza, Sandra;
- Gandhi, Alex;
- Liebes, Leonard;
- Pavlick, Anna
Publication type:
Article
Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 43, doi. 10.1007/s00280-012-1970-3
By:
- Kang, Yoon-Koo;
- Kang, Byung;
- Im, Seock-Ah;
- Lee, Jae-Lyun;
- Park, Sook;
- Kang, Won;
- Chang, Heung;
- Kim, Tae;
- Oh, Do-Youn;
- Jung, Kyung;
- Ryu, Min-Hee
Publication type:
Article
Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 165, doi. 10.1007/s00280-012-1993-9
By:
- Park, Mi;
- Kim, Seung;
- Park, Jun;
- Kim, Do;
- Ahn, Sang;
- Han, Kwang;
- Chon, Chae;
- Seong, Jinsil
Publication type:
Article
Effects of famotidine or an antacid preparation on the pharmacokinetics of nilotinib in healthy volunteers.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 219, doi. 10.1007/s00280-012-1999-3
By:
- Yin, Ophelia;
- Bédoucha, Véronique;
- McCulloch, Tracey;
- Zheng, Cheng;
- Zhou, Wei;
- Hussaini, Azra;
- Novick, Steven
Publication type:
Article
Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 123, doi. 10.1007/s00280-012-1987-7
By:
- Abbas, Richat;
- Chalon, Stephan;
- Leister, Cathie;
- Gaaloul, Myriam;
- Sonnichsen, Daryl
Publication type:
Article
Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 175, doi. 10.1007/s00280-012-1994-8
By:
- Miyahara, T.;
- Mochinaga, S.;
- Kimura, S.;
- Aragane, N.;
- Yakabe, T.;
- Morita, S.;
- Okudaira, K.;
- Fujito, H.
Publication type:
Article
Phase 1 study of trebananib (AMG 386), an angiogenesis targeting angiopoietin-1/2 antagonist, in Japanese patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 227, doi. 10.1007/s00280-012-2000-1
By:
- Doi, Toshihiko;
- Ohtsu, Atsushi;
- Fuse, Nozomu;
- Yoshino, Takayuki;
- Tahara, Makoto;
- Shibayama, Kazuhiro;
- Takubo, Takatoshi;
- Weinreich, David
Publication type:
Article
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 21, doi. 10.1007/s00280-012-1917-8
By:
- Gordon, Michael;
- Ilaria, Robert;
- Alwis, Dinesh;
- Mendelson, David;
- McKane, Scott;
- Wagner, Margaret;
- Look, Katherine;
- LoRusso, Patricia
Publication type:
Article
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe study.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 257, doi. 10.1007/s00280-012-2004-x
By:
- Rosati, Gerardo;
- Avallone, Antonio;
- Aprile, Giuseppe;
- Butera, Alfredo;
- Reggiardo, Giorgio;
- Bilancia, Domenico
Publication type:
Article
Co-administration of vismodegib with rosiglitazone or combined oral contraceptive in patients with locally advanced or metastatic solid tumors: a pharmacokinetic assessment of drug-drug interaction potential.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 193, doi. 10.1007/s00280-012-1996-6
By:
- LoRusso, Patricia;
- Piha-Paul, Sarina;
- Mita, Monica;
- Colevas, A.;
- Malhi, Vikram;
- Colburn, Dawn;
- Yin, Ming;
- Low, Jennifer;
- Graham, Richard
Publication type:
Article
Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 115, doi. 10.1007/s00280-012-1986-8
By:
- Chu, B.;
- Karpenko, M.;
- Liu, Z.;
- Aimiuwu, J.;
- Villalona-Calero, M.;
- Chan, K.;
- Grever, M.;
- Otterson, G.
Publication type:
Article
Erlotinib in patients with advanced lung squamous cell carcinoma.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 203, doi. 10.1007/s00280-012-1997-5
By:
- Chiang, Chi-Lu;
- Tsai, Chun-Ming;
- Chou, Teh-Ying;
- Chen, Yuh-Min;
- Lai, Shinn-Liang;
- Shih, Jen-Fu;
- Chiu, Chao-Hua;
- Lee, Yu-Chin
Publication type:
Article
Effect of abiraterone acetate plus prednisone on the pharmacokinetics of dextromethorphan and theophylline in patients with metastatic castration-resistant prostate cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 237, doi. 10.1007/s00280-012-2001-0
By:
- Chi, K.;
- Tolcher, A.;
- Lee, P.;
- Rosen, P.;
- Kollmannsberger, C.;
- Papadopoulos, K.;
- Patnaik, A.;
- Molina, A.;
- Jiao, J.;
- Pankras, C.;
- Kaiser, B.;
- Bernard, A.;
- Tran, N.;
- Acharya, M.
Publication type:
Article
Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 73, doi. 10.1007/s00280-012-1980-1
By:
- Parise, Robert;
- Anyang, Bean;
- Eiseman, Julie;
- Egorin, Merrill;
- Covey, Joseph;
- Beumer, Jan
Publication type:
Article
Assessing the in vivo efficacy of biologic antiangiogenic therapies.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 1, doi. 10.1007/s00280-012-1978-8
By:
- Wilson, Peter;
- LaBonte, Melissa;
- Lenz, Heinz-Josef
Publication type:
Article
Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 13, doi. 10.1007/s00280-012-1984-x
By:
- Kartal Yandım, Melis;
- Apohan, Elif;
- Baran, Yusuf
Publication type:
Article
A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 93, doi. 10.1007/s00280-012-1982-z
By:
- Plummer, Ruth;
- Madi, Ayman;
- Jeffels, Melinda;
- Richly, Heike;
- Nokay, Bahar;
- Rubin, Stephen;
- Ball, Howard;
- Weller, Steve;
- Botbyl, Jeffrey;
- Gibson, Diana;
- Scheulen, Max
Publication type:
Article
Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 35, doi. 10.1007/s00280-012-1963-2
By:
- Nemunaitis, John;
- Mita, Alain;
- Stephenson, Joe;
- Mita, Monica;
- Sarantopoulos, John;
- Padmanabhan-Iyer, Swami;
- Nanda, Nisha;
- Gleich, Lyon;
- Benichou, Annie-Claude;
- Craig, Adam
Publication type:
Article
Hemodialysis no reason to withhold everolimus.
Published in:
2013
By:
- Rooijen, J.;
- Vries, E.
Publication type:
Letter
Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor.
Published in:
Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 1, p. 145, doi. 10.1007/s00280-012-1991-y
By:
- Cui, Yuehong;
- Li, Qian;
- Yu, Yiyi;
- Chen, Yong;
- Feng, Yi;
- Wang, Yan;
- Liu, Tianshu
Publication type:
Article